Sysmex Expands Portfolio and Accelerates Global Expansion through Acquisition of JEOL's Clinical Chemistry Testing Business

FierceBiotechAmgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data

BioPharma DiveTwo biotechs raise a combined $556M in latest spurt of IPOs

Merck & Co.Spotlight On: Merck & Co. maintains BD appetite ahead of $70B sales goal - FirstWord Pharma

Siemens HealthineersSiemens Healthineers Faces a Reckoning: Diagnostics Sale, Spin-Off Delays, and a Stock at Rock Botto - AD HOC NEWS

Thermo FisherHow Investors Are Reacting To Thermo Fisher Scientific (TMO) Expanding Its U.S. Bioprocess Design Center - Yahoo Finance

Siemens HealthineersARPA-H awards Siemens Healthineers up to $60M for Flash radiotherapy - AuntMinnie

IlluminaIllumina Reports Financial Results for First Quarter of Fiscal Year 2026 - PR Newswire

ScienceDeepfakes are everywhere. The godfather of digital forensics is fighting back

Endpoints NewsFDA's oncology advisors vote against 'new paradigm' in AstraZeneca trial

Endpoints NewsKrazati fails confirmatory trial in colorectal cancer, putting approval at risk

10x Genomics BlogWhy 10x Genomics Stock Is Surging Today - TipRanks

FierceBiotechAstraZeneca's camizestrant ambitions stumble as FDA panel rejects novel oral SERD proposal